Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BRKR | US
-3.45
-8.70%
Healthcare
Diagnostics & Research
30/06/2024
23/04/2026
36.22
38.43
38.67
34.88
Bruker Corporation together with its subsidiaries develops manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin BSI CALID BSI NANO and Bruker Energy & Supercon Technologies. It offers life science tools and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits DNA test strips and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research analytical and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems and related products; X-ray instruments; analytical tools for electron microscopes as well as handheld portable and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology automated AFM defect-detection and photomask repair and cleaning equipment. In addition the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research drug and biomarker discovery; superconducting materials such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica Massachusetts.
View LessStrong Revenue Growth (> 10%)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
56.4%1 month
50.3%3 months
49.3%6 months
46.6%26.13
23.64
5.12
1.27
0.38
17.92
3.61
3.64
572.00M
5.48B
5.48B
0.33
10.08
-87.10
17.40
22.86
3.77
3.85
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
7.76
Range1M
9.53
Range3M
21.13
Rel. volume
1.71
Price X volume
114.44M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings Inc | LNTH | Diagnostics & Research | 82.82 | 5.75B | -0.07% | 19.19 | 60.42% |
| Sotera Health Company | SHC | Diagnostics & Research | 15.33 | 4.34B | -1.92% | 114.29 | 555.18% |
| Celcuity Inc | CELC | Diagnostics & Research | 113.56 | 4.21B | -7.24% | n/a | 54.62% |
| RadNet Inc | RDNT | Diagnostics & Research | 56.44 | 4.17B | -2.40% | 378.67 | 195.04% |
| Senseonics Holdings Inc | SENS | Diagnostics & Research | 7 | 3.75B | n/a | 154.97% | |
| Twist Bioscience Corporation | TWST | Diagnostics & Research | 58.85 | 3.45B | -6.88% | n/a | 17.75% |
| Soleno Therapeutics Inc | SLNO | Diagnostics & Research | 52.83 | 2.05B | 0.15% | n/a | 0.11% |
| Neogen Corporation | NEOG | Diagnostics & Research | 9.35 | 2.03B | -1.79% | n/a | 28.45% |
| Biodesix Inc | BDSX | Diagnostics & Research | 9.96 | 1.45B | -13.99% | n/a | 169.94% |
| CareDx Inc | CDNA | Diagnostics & Research | 20.06 | 1.06B | -2.76% | n/a | 11.88% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc | DLB | Media - Diversified | 62.96 | 6.00B | -3.03% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.4 | 5.14B | 2.15% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 78.81 | 4.17B | 1.04% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.6 | 3.50B | 0.25% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 26.99 | 3.36B | -6.90% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 59.41 | 3.31B | 1.50% | 14.48 | 170.51% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.38 | 3.08B | 1.96% | 7.33 | 218.58% |
| LCI Industries | LCII | Recreational Vehicles | 120.55 | 3.07B | 0.73% | 25.82 | 77.66% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.37 | 2.76B | 0.99% | n/a | -571.93% |
| IMAX Corporation | IMAX | Media - Diversified | 36.61 | 1.93B | 1.08% | 54.26 | 110.44% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 17.92 | 12.67 | Expensive |
| Ent. to Revenue | 3.61 | 44.00 | Cheaper |
| PE Ratio | 26.13 | 40.09 | Cheaper |
| Price to Book | 5.12 | 77.50 | Cheaper |
| Dividend Yield | 0.33 | 1.18 | Poor |
| Std. Deviation (3M) | 49.31 | 59.59 | Par |
| Debt to Equity | 1.27 | -14.36 | Expensive |
| Debt to Assets | 0.38 | 0.34 | Par |
| Market Cap | 5.48B | 13.71B | Emerging |